Eton Pharmaceuticals (ETON) Assets Average (2018 - 2026)
Eton Pharmaceuticals (ETON) posted Assets Average of $98.3 million for Q4 2025, down 4.64% sequentially from $103.1 million in Q3 2025, and up 75.61% YoY from $56.0 million in Q4 2024.
Eton Pharmaceuticals (ETON) Assets Average (2018 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Assets Average for 8 years, with the latest figure at $98.3 million in Q4 2025.
- Quarterly Assets Average rose 75.61% year-over-year to $98.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $98.3 million (up 75.61% YoY) and the FY2025 annual result came in at $84.1 million, up 55.97% from the prior year.
- Assets Average declined to $98.3 million in Q4 2025 per ETON's latest filing, from $103.1 million in the prior quarter.
- Over five years, Assets Average peaked at $103.1 million in Q3 2025 and troughed at $22.3 million in Q3 2022.
- A 5-year average of $42.5 million and a median of $30.9 million in 2021 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2025: Assets Average declined 24.31% in 2022, then surged 204.72% in 2025.
- Over 5 years, Assets Average stood at $27.0 million in 2021, then declined by 13.91% to $23.3 million in 2022, then jumped by 35.91% to $31.6 million in 2023, then soared by 76.97% to $56.0 million in 2024, then soared by 75.61% to $98.3 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $98.3 million, $103.1 million, and $92.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 103.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103.96 Mn |
| Dec 31, 2025 | 98.31 Mn |
| Sep 30, 2025 | 103.09 Mn |
| Jun 30, 2025 | 92.85 Mn |
| Mar 31, 2025 | 80.08 Mn |
| Dec 31, 2024 | 55.98 Mn |
| Sep 30, 2024 | 33.83 Mn |
| Jun 30, 2024 | 31.31 Mn |
| Mar 31, 2024 | 31.27 Mn |
| Dec 31, 2023 | 31.63 Mn |
| Sep 30, 2023 | 31.23 Mn |
| Jun 30, 2023 | 27.43 Mn |
| Mar 31, 2023 | 24.48 Mn |
| Dec 31, 2022 | 23.28 Mn |
| Sep 30, 2022 | 22.28 Mn |
| Jun 30, 2022 | 23.12 Mn |
| Mar 31, 2022 | 25.33 Mn |
| Dec 31, 2021 | 27.04 Mn |
| Sep 30, 2021 | 28.26 Mn |
| Jun 30, 2021 | 30.55 Mn |